Navigation Links
National Press Club Celebration of the Publication of "The Grace of Stem Cells" by Jeong Chan Ra, Chairman of RNL BIO
Date:10/25/2012

SEOUL, South Korea, Oct. 25, 2012 /PRNewswire/ -- The Grace of Stem Cells by Dr. Jeong Chan Ra, biomedical scientist and Chairman of RNL BIO, was published by October 24, 2012.  At the National Press Club, leaders from around the world and the media gathered to discuss Dr. Ra's claim that huge amounts of peer reviewed data is systematically ignored in order that opponents of ethical stem cell research are able to promote unsuccessful, unsafe embryonic strategies.  Dr. Ra is Chairman of RNL BIO, itself a leader in stem cell translational research.

The Grace of Stem Cells is the first comprehensive analysis of adult stem cell interventions to be published in the English language, and was hailed by leaders for its equally profound story of the relationship between Christian faith and a scientific approach to stem cell research.

Dr. Ra's previous work includes dozens of scientific papers and a book that has sold over 30,000 copies and is ranked one of the best-sellers in science books in Asia.

Emeritus President of the Southern Baptist Convention and one of America's most influential religious leaders Dr. Morris Chapman joined others from America and abroad to celebrate the work as, to quote Dr. Chapman, "the most important book for pro-life advocates on this subject to be published … ever."

Patients who had received treatment for incurable diseases using their own (autologous) stem cells were both in attendance and spoke of Dr. Ra's story.  Chloe Sohl, who lost her hearing to autoimmune hearing loss, told her story.  But the discussion pivoted not on the stories of individuals but the huge amount of published data of recent origin and its effect on the huge demand for stem cells.

Dr. Jeong Chan Ra stated, "As much controversy and issues of safety are concerned in the field of stem cells or embryonic stem cells, autologous adult stem cells are derived from cells that already exist in our bodies to help us treat all kinds of diseases, which is a reminder of God's omnipotence." 

Dr. Ra added, "I sincerely hope The Grace of Stem Cells instills faith to people with incurable diseases to be treated."   He described the complete commitment of RNL BIO and its partners and friends to bioethics, to protection of life, and to aggressive and systematic research and translational medicine and educational programs.  He also discussed the recent and extraordinary growth of RNL BIO and what his plans include for the future.

All royalties from the publications in the United States will be donated to Bethesda Life Foundation in Tennessee, USA. The book is now available in paper as well as e-book at amazon.com.


'/>"/>
SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ABTCP: Internationale Krise beeinflusst den Papier- und Zellstoffmarkt, doch Brasilien investiert weiterhin in Innovationen
2. National Association of Specialty Pharmacy (NASP) Plans Launch
3. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
4. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
5. VWR International, LLC Acquires Sovereign Group
6. Frost & Sullivan Recognizes A*STAR, Singapore with the 2012 Asia Pacific National Innovation Development Award
7. Ohio State Hosting International Personalized Health Care Leaders
8. Micropharma Convenes Expert Roundtable on New Role for Probiotics in Cardiovascular Disease in time for National Cholesterol Education Month
9. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
10. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
11. Yongye International Announces Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):